The Securities Markets Code, 2025: Strengthened Enforcement, Weakened Accountability? (See 'CORP EINSICHT') India far more urban in functional terms than official definitions: Survey (See 'Corp Brief') Economic Survey lays stress on swadeshi for strategic resilience (See 'Corp Brief') 5G services now available in over 99% districts (See 'Corp Brief') Survey asks States to focus on entrepreneurial policy making (See 'Corp Brief') Health insurance accounts for 41% of Gross Domestic Premium (See 'Corp Brief') IBC - NCLT can't decide title disputes over assets, including IPRs such as trademarks, unless they have direct & proximate nexus with insolvency resolution process: SC (See 'Legal Desk') 'Vande Mataram', 'Anand Math', 'Atulya Bharat' tunes to regale audience at Beating Retreat ceremony (See 'Corp Brief') Youth Lead Democracy: Model Youth Gram Sabha Awards Conferred in Delhi (See 'Corp Brief') Misc - Execution sale during pendency of insolvency proceedings held void; Official Receiver can seek annulment even without expressly invoking Section 56: HC (See 'Legal Desk') Union fisheries secretary engages shrimp farmers, boosts scientific innovation in aquaculture (See 'Corp Brief') Learjet 45 aircraft VT-SSK crash at Baramati Airport of M/s VSR Ventures PVT LTD (See 'Corp Brief') SAFEMA - contravention of Sections 3(d) and 7(1)(a)can be established based on documentary evidence & circumstantial corroboration applying the standard of preponderance of probabilities, even in absence of direct evidence of cash payment: SAFEMA (See 'Legal Desk') CCI nod to acquisition of certain shareholding of Toyota Industries Corp (See 'Corp Brief') IBC - Resolution Professionals under IBC are public servants under Prevention of Corruption Act: HC (See 'Legal Desk') Department of Posts signs Agreement with Stock Holding Services Limited for access to capital market services (See 'Corp Brief') SEBI - Failure to make timely disclosure of material developments relating to a proposed scheme of arrangement & delayed disclosure of outcome of board meeting constitutes violation of LODR Regulations: SEBI (See 'Legal Desk') MSME beneficiaries invited as special guests for R-Day celebrations (See 'Corp Brief') PMLA - Offence of money-laundering is independent offence regarding process or activity connected with proceeds of crime which had been derived or obtained as result of criminal activity relating to or in relation to scheduled offence: SAFEMA (See 'Legal Desk')

Print

CCI okays internal acquisition by Glaxo Smith Kline

Published: Jan 24, 2022

By TIOLCorplaws News Service

NEW DELHI, JAN 24, 2022: THE Competition Commission of India (CCI) approves acquisition by GlaxoSmithKline Consumer Healthcare Overseas Limited and GlaxoSmithKline Consumer Healthcare UK Trading Limited (Acquirers) of shareholding in GlaxoSmithKline Asia Private Limited (Target) under Section 31(1) of the Competition Act, 2002.

The Proposed Combination involves collective acquisition of 100% shares of the Target by the Acquirers. Further, prior to the proposed combination, GSKAPL will acquire the trademarks pertaining to "Iodex" and "Ostocalcium" brands in India alongwith the legal, economic, commercial and marketing rights of such brands and other associated assets (GSK Consumer Brands) from GlaxoSmithKline Pharmaceuticals Limited.

GlaxoSmithKline Consumer Healthcare Overseas Limited is a wholly-owned subsidiary of GlaxoSmithKline Consumer Healthcare Holdings (No.2) Limited ("GSK CH HoldCo"). It is a part of the overall GlaxoSmithkline (GSK) group and its principal activity is to act as an investment holding company for GSK CH HoldCo and its subsidiaries.

GlaxoSmithKline Consumer Healthcare UK Trading Limited is a part of the overall GSK group and is a wholly-owned subsidiary of GSK CH HoldCo. It is engaged in the distribution and sale of consumer healthcare products, manufacturing, marketing, providing management services to the consumer healthcare group and providing research and development services to other consumer healthcare companies within the GSK group.

GSKAPL is a consumer healthcare company that is engaged in the marketing and distribution of oral healthcare products under various brand names such as Sensodyne, Parodontax, Polident and over-the-counter medicines products under the brand names such as Crocin, ENO. 

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.